Exact Sciences
EXAS
#1156
Rank
C$26.50 B
Marketcap
C$139.68
Share price
0.14%
Change (1 day)
61.63%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

Earnings for Exact Sciences (EXAS)

Earnings in 2025 (TTM): -C$1.4 Billion

According to Exact Sciences's latest financial reports the company's current earnings are C$3.08 Billion. In 2024 the company made an earning of -C$1.4 Billion a decrease over its 2023 earnings that were of -C$0.27 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Exact Sciences from 2001 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -C$1.4 Billion-0.4%
2024 -C$1.4 Billion435.05%
2023 -C$0.27 Billion-69.18%
2022 -C$0.85 Billion-25.77%
2021 -C$1.15 Billion1.68%
2020 -C$1.13 Billion271.17%
2019 -C$0.31 Billion58.99%
2018 -C$0.2 Billion20.89%
2017 -C$0.16 Billion-30.95%
2016 -C$0.23 Billion5.09%
2015 -C$0.22 Billion57.24%
2014 -C$0.14 Billion116.53%
2013 -C$63.72 Million
2011 -C$39.67 Million143.73%
2010 -C$16.28 Million27.85%
2009 -C$12.73 Million0.27%
2008 -C$12.7 Million-20.95%
2007 -C$16.07 Million-13.53%
2006 -C$18.58 Million-10.07%
2005 -C$20.66 Million-21.81%
2004 -C$26.42 Million-33.44%
2003 -C$39.69 Million-6.51%
2002 -C$42.45 Million17.95%
2001 -C$35.99 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Myriad Genetics
MYGN
-C$0.58 Billion-56.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Antares Pharma
ATRS
C$90.66 M-106.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Veracyte
VCYT
C$34.05 M-102.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Biocept
BIOC
-C$48.13 Million-96.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
C$12.52 B-1,038.16%๐Ÿ‡ซ๐Ÿ‡ท France